EXICURE, INC. Other Nonoperating Income (Expense)
EXICURE, INC. (XCUR) reported Other Nonoperating Income (Expense) of -$26.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-14
- EXICURE, INC. other nonoperating income (expense) for the quarter ending 2026-06-30 was -$26.00K.
- EXICURE, INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was -$255.00K.
- EXICURE, INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$11.00K, a 100.73% decline year-over-year.
- EXICURE, INC. other nonoperating income (expense) for the quarter ending 2025-06-30 was -$9.00K, a 101.43% decline year-over-year.
- EXICURE, INC. other nonoperating income (expense) for fiscal 2025 was -$275.00K, a 112.87% decline from fiscal 2024.
- EXICURE, INC. other nonoperating income (expense) for fiscal 2024 was $2.14M.
- EXICURE, INC. other nonoperating income (expense) for fiscal 2023 was -$2.00K.
- EXICURE, INC. other nonoperating income (expense) for fiscal 2022 was -$40.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$26.00K 10-Q · filed 2026-08-14 | -$26.00K 10-Q · filed 2026-08-14 | ||||||
| 2025-12-31 | -$255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$266.00K derived: sum of 2 quarters · filed 2026-03-25 | -$275.00K derived: sum of 3 quarters · filed 2026-08-14 | -$275.00K 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$11.00K 10-Q · filed 2025-11-07 | -$20.00K derived: sum of 2 quarters · filed 2026-08-14 | -$20.00K 10-Q · filed 2025-11-07 | -$46.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | -$9.00K 10-Q · filed 2026-08-14 | -$9.00K 10-Q · filed 2026-08-14 | -$35.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.47M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | -$26.00K 10-Q · filed 2025-06-27 | -$26.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.47M derived: sum of 3 quarters · filed 2026-03-25 | $2.10M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.50M derived: sum of 2 quarters · filed 2026-03-25 | $2.13M derived: sum of 3 quarters · filed 2026-03-25 | $2.14M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $1.50M 10-Q · filed 2025-11-07 | $2.13M derived: sum of 2 quarters · filed 2025-11-07 | $2.14M 10-Q · filed 2025-11-07 | $2.13M derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | $631.00K 10-Q · filed 2025-08-08 | $631.00K 10-Q · filed 2025-08-08 | $631.00K derived: sum of 3 quarters · filed 2025-08-08 | $675.00K derived: sum of 4 quarters · filed 2025-08-08 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-06-27 | $0.00 derived: sum of 2 quarters · filed 2025-06-27 | $44.00K derived: sum of 3 quarters · filed 2025-06-27 | -$106.00K derived: sum of 4 quarters · filed 2025-06-27 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $44.00K derived: sum of 2 quarters · filed 2025-03-18 | -$106.00K derived: sum of 3 quarters · filed 2025-03-18 | -$2.00K 10-K · filed 2025-03-18 | ||||
| 2023-09-30 | $44.00K 10-Q · filed 2024-11-14 | -$106.00K derived: sum of 2 quarters · filed 2024-11-14 | -$2.00K 10-Q · filed 2024-11-14 | -$18.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$150.00K 10-Q · filed 2024-08-13 | -$46.00K 10-Q · filed 2024-08-13 | -$62.00K derived: sum of 3 quarters · filed 2024-08-13 | -$62.00K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $104.00K 10-Q · filed 2024-06-17 | $88.00K derived: sum of 2 quarters · filed 2024-06-17 | $88.00K derived: sum of 3 quarters · filed 2024-06-17 | $84.00K derived: sum of 4 quarters · filed 2024-06-17 | ||||
| 2022-12-31 | -$16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | -$16.00K derived: sum of 2 quarters · filed 2024-06-06 | -$20.00K derived: sum of 3 quarters · filed 2024-06-06 | -$40.00K 10-K · filed 2024-06-06 | ||||
| 2022-09-30 | $0.00 10-Q · filed 2024-05-16 | -$4.00K derived: sum of 2 quarters · filed 2024-06-06 | -$24.00K 10-Q · filed 2024-05-16 | -$28.00K derived: sum of 4 quarters · filed 2024-06-06 | ||||
| 2022-06-30 | -$4.00K 10-Q/A · filed 2024-06-06 | -$24.00K 10-Q/A · filed 2024-06-06 | -$28.00K derived: sum of 3 quarters · filed 2024-06-06 | -$33.00K derived: sum of 4 quarters · filed 2024-06-06 | ||||
| 2022-03-31 | -$20.00K 10-Q/A · filed 2024-06-06 | -$24.00K derived: sum of 2 quarters · filed 2024-06-06 | -$29.00K derived: sum of 3 quarters · filed 2024-06-06 | -$31.00K derived: sum of 4 quarters · filed 2024-06-06 | ||||
| 2021-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$9.00K derived: sum of 2 quarters · filed 2023-03-27 | -$11.00K derived: sum of 3 quarters · filed 2023-03-27 | -$11.00K 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | -$5.00K 10-Q · filed 2022-11-14 | -$7.00K derived: sum of 2 quarters · filed 2022-11-14 | -$7.00K 10-Q · filed 2022-11-14 | $44.00K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$2.00K 10-Q · filed 2022-08-15 | -$2.00K 10-Q · filed 2022-08-15 | $49.00K derived: sum of 3 quarters · filed 2022-08-15 | $167.00K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | $51.00K derived: sum of 2 quarters · filed 2022-05-16 | $169.00K derived: sum of 3 quarters · filed 2022-05-16 | -$23.00K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $169.00K derived: sum of 2 quarters · filed 2022-03-25 | -$23.00K derived: sum of 3 quarters · filed 2022-03-25 | $322.00K 10-K · filed 2022-03-25 | ||||
| 2020-09-30 | $118.00K 10-Q · filed 2021-11-19 | -$74.00K derived: sum of 2 quarters · filed 2021-11-19 | $271.00K 10-Q · filed 2021-11-19 | $293.00K derived: sum of 4 quarters · filed 2021-11-19 | ||||
| 2020-06-30 | -$192.00K 10-Q · filed 2021-08-12 | $153.00K 10-Q · filed 2021-08-12 | $175.00K derived: sum of 3 quarters · filed 2021-08-12 | $279.00K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $345.00K 10-Q · filed 2021-05-12 | $367.00K derived: sum of 2 quarters · filed 2021-05-12 | $471.00K derived: sum of 3 quarters · filed 2021-05-12 | $355.00K derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $126.00K derived: sum of 2 quarters · filed 2021-03-11 | $10.00K derived: sum of 3 quarters · filed 2021-03-11 | $379.00K 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $104.00K 10-Q · filed 2020-11-12 | $333.00K 10-Q · filed 2019-11-07 | -$12.00K derived: sum of 2 quarters · filed 2020-11-12 | $357.00K 10-Q · filed 2020-11-12 | $775.00K 10-Q · filed 2019-11-07 | $318.00K derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | -$116.00K 10-Q · filed 2020-08-12 | -$33.00K 10-Q · filed 2019-08-08 | $253.00K 10-Q · filed 2020-08-12 | $442.00K 10-Q · filed 2019-08-08 | $214.00K derived: sum of 3 quarters · filed 2020-08-12 | $923.00K derived: sum of 4 quarters · filed 2020-08-12 | ||
| 2019-03-31 | $369.00K 10-Q · filed 2020-05-14 | $475.00K 10-Q · filed 2019-05-08 | $330.00K derived: sum of 2 quarters · filed 2020-05-14 | $1.04M derived: sum of 3 quarters · filed 2020-05-14 | $184.00K derived: sum of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | -$39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $670.00K derived: sum of 2 quarters · filed 2020-03-10 | -$185.00K derived: sum of 3 quarters · filed 2020-03-10 | -$249.00K 10-K · filed 2020-03-10 | $78.00K 10-K · filed 2019-03-08 | |||
| 2018-09-30 | $709.00K 10-Q · filed 2019-11-07 | -$146.00K derived: sum of 2 quarters · filed 2019-11-07 | -$210.00K 10-Q · filed 2019-11-07 | -$159.00K derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$855.00K 10-Q · filed 2019-08-08 | -$919.00K 10-Q · filed 2019-08-08 | -$868.00K derived: sum of 3 quarters · filed 2019-09-23 | -$705.00K derived: sum of 4 quarters · filed 2019-09-23 | ||||
| 2018-03-31 | -$64.00K 10-Q · filed 2019-05-08 | -$13.00K derived: sum of 2 quarters · filed 2019-09-23 | $150.00K derived: sum of 3 quarters · filed 2019-09-23 | $93.00K derived: sum of 4 quarters · filed 2019-09-23 | ||||
| 2017-12-31 | $51.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | $214.00K derived: sum of 2 quarters · filed 2019-09-23 | $157.00K derived: sum of 3 quarters · filed 2019-09-23 | $191.00K 10-K/A · filed 2019-09-23 | ||||
| 2017-09-30 | $163.00K 10-Q · filed 2018-11-06 | $106.00K derived: sum of 2 quarters · filed 2018-11-06 | $140.00K 10-Q · filed 2018-11-06 | $149.00K derived: sum of 4 quarters · filed 2018-11-06 | ||||
| 2017-06-30 | -$57.00K 10-Q · filed 2018-08-06 | -$23.00K 10-Q · filed 2018-08-06 | -$14.00K derived: sum of 3 quarters · filed 2018-08-06 | -$70.00K derived: sum of 4 quarters · filed 2018-08-06 | ||||
| 2017-03-31 | $34.00K 10-Q · filed 2018-05-15 | $43.00K derived: sum of 2 quarters · filed 2018-05-15 | -$13.00K derived: sum of 3 quarters · filed 2018-05-15 | |||||
| 2016-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$47.00K derived: sum of 2 quarters · filed 2018-03-09 | -$55.00K 10-K · filed 2018-03-09 | |||||
| 2016-09-30 | -$56.00K 10-Q · filed 2017-11-14 | -$64.00K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |